Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy

Diabetes - United States
doi 10.2337/db11-0807
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association